These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Of embryos and tumors: Cyclopia and the relevance of mechanistic teratology. DeSesso JM Birth Defects Res; 2020 Feb; 112(3):219-233. PubMed ID: 31883318 [TBL] [Abstract][Full Text] [Related]
23. Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells. Dwyer JR; Sever N; Carlson M; Nelson SF; Beachy PA; Parhami F J Biol Chem; 2007 Mar; 282(12):8959-68. PubMed ID: 17200122 [TBL] [Abstract][Full Text] [Related]
24. Dose- and route-dependent teratogenicity, toxicity, and pharmacokinetic profiles of the hedgehog signaling antagonist cyclopamine in the mouse. Lipinski RJ; Hutson PR; Hannam PW; Nydza RJ; Washington IM; Moore RW; Girdaukas GG; Peterson RE; Bushman W Toxicol Sci; 2008 Jul; 104(1):189-97. PubMed ID: 18411234 [TBL] [Abstract][Full Text] [Related]
25. Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified. Wilson SR; Strand MF; Krapp A; Rise F; Petersen D; Krauss S J Pharm Biomed Anal; 2010 Sep; 52(5):707-13. PubMed ID: 20236786 [TBL] [Abstract][Full Text] [Related]
26. Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo). Zhang X; Harrington N; Moraes RC; Wu MF; Hilsenbeck SG; Lewis MT Breast Cancer Res Treat; 2009 Jun; 115(3):505-21. PubMed ID: 18563554 [TBL] [Abstract][Full Text] [Related]
27. From teratogens to potential therapeutics: natural inhibitors of the Hedgehog signaling network come of age. Hovhannisyan A; Matz M; Gebhardt R Planta Med; 2009 Oct; 75(13):1371-80. PubMed ID: 19639534 [TBL] [Abstract][Full Text] [Related]
28. Effect of the Hedgehog-inhibitor cyclopamine on mice with osteosarcoma pulmonary metastases. Warzecha J; Dinges D; Kaszap B; Henrich D; Marzi I; Seebach C Int J Mol Med; 2012 Mar; 29(3):423-7. PubMed ID: 22138977 [TBL] [Abstract][Full Text] [Related]
29. Cyclopamine: inhibiting hedgehog in the treatment of psoriasis. Meth MJ; Weinberg JM Cutis; 2006 Sep; 78(3):185-8. PubMed ID: 17036662 [TBL] [Abstract][Full Text] [Related]
30. Endogenous B-ring oxysterols inhibit the Hedgehog component Smoothened in a manner distinct from cyclopamine or side-chain oxysterols. Sever N; Mann RK; Xu L; Snell WJ; Hernandez-Lara CI; Porter NA; Beachy PA Proc Natl Acad Sci U S A; 2016 May; 113(21):5904-9. PubMed ID: 27162362 [TBL] [Abstract][Full Text] [Related]
31. Hedgehog antagonists cyclopamine and dihydroveratramine can be mistaken for each other in Veratrum album. Wilson SR; Strand MF; Krapp A; Rise F; Herstad G; Malterud KE; Krauss S J Pharm Biomed Anal; 2010 Nov; 53(3):497-502. PubMed ID: 20646889 [TBL] [Abstract][Full Text] [Related]
32. Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Mukherjee S; Frolova N; Sadlonova A; Novak Z; Steg A; Page GP; Welch DR; Lobo-Ruppert SM; Ruppert JM; Johnson MR; Frost AR Cancer Biol Ther; 2006 Jun; 5(6):674-83. PubMed ID: 16855373 [TBL] [Abstract][Full Text] [Related]
33. Targeting the hedgehog pathway: the development of cyclopamine and the development of anti-cancer drugs targeting the hedgehog pathway. Gould A; Missailidis S Mini Rev Med Chem; 2011 Mar; 11(3):200-13. PubMed ID: 21222574 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of the hedgehog pathway leads to antifibrotic effects in dermal fibrosis. Cao HL; Zhou J; Chen XB; Landeck L; Yang JQ; Chen JQ; Li W; Cai SQ; Zheng M; Man XY Discov Med; 2016 Nov; 22(122):311-318. PubMed ID: 28009972 [TBL] [Abstract][Full Text] [Related]
35. Identification of a potent antagonist of smoothened in hedgehog signaling. Fan J; Li H; Kuang L; Zhao Z; He W; Liu C; Wang Y; Cheng SY; Chen W Cell Biosci; 2021 Mar; 11(1):46. PubMed ID: 33653381 [TBL] [Abstract][Full Text] [Related]
36. Sonic hedgehog signaling plays an essential role during embryonic salivary gland epithelial branching morphogenesis. Jaskoll T; Leo T; Witcher D; Ormestad M; Astorga J; Bringas P; Carlsson P; Melnick M Dev Dyn; 2004 Apr; 229(4):722-32. PubMed ID: 15042696 [TBL] [Abstract][Full Text] [Related]
37. Treatment of eyelid epithelial neoplasm by targeting sonic hedgehog signaling: an experimental study. Miyazaki KI; Saika S; Yamanaka O; Okada Y; Ohnishi Y Jpn J Ophthalmol; 2006; 50(4):305-311. PubMed ID: 16897213 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory potential of postnatal treatment with cyclopamine, a hedgehog signaling inhibitor, on medulloblastoma development in Ptch1 heterozygous mice. Matsuo S; Takahashi M; Inoue K; Tamura K; Irie K; Kodama Y; Nishikawa A; Yoshida M Toxicol Pathol; 2014 Dec; 42(8):1174-87. PubMed ID: 24862798 [TBL] [Abstract][Full Text] [Related]
39. Cyclopamine inhibition of Sonic hedgehog signal transduction is not mediated through effects on cholesterol transport. Incardona JP; Gaffield W; Lange Y; Cooney A; Pentchev PG; Liu S; Watson JA; Kapur RP; Roelink H Dev Biol; 2000 Aug; 224(2):440-52. PubMed ID: 10926779 [TBL] [Abstract][Full Text] [Related]
40. Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastoma. Balbous A; Renoux B; Cortes U; Milin S; Guilloteau K; Legigan T; Rivet P; Boissonnade O; Martin S; Tripiana C; Wager M; Bensadoun RJ; Papot S; Karayan-Tapon L Mol Cancer Ther; 2014 Sep; 13(9):2159-69. PubMed ID: 25053823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]